2-[(5S,10S,14S)-14-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-3,6,9,12,15-pentaoxo-1,19-dioxa-4,7,8,11,13,16-hexazacyclohenicos-10-yl]acetamide

ID: ALA5278932

Max Phase: Preclinical

Molecular Formula: C18H31N7O10

Molecular Weight: 505.49

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](O)[C@@H]1NC(=O)N[C@@H](CC(N)=O)C(=O)NNC(=O)[C@H](CO)NC(=O)COCCOCCNC1=O

Standard InChI:  InChI=1S/C18H31N7O10/c1-9(27)14-17(32)20-2-3-34-4-5-35-8-13(29)21-11(7-26)16(31)25-24-15(30)10(6-12(19)28)22-18(33)23-14/h9-11,14,26-27H,2-8H2,1H3,(H2,19,28)(H,20,32)(H,21,29)(H,24,30)(H,25,31)(H2,22,23,33)/t9-,10-,11-,14-/m0/s1

Standard InChI Key:  RNLBHYADPZOJMB-RMIALFOJSA-N

Molfile:  

 
     RDKit          2D

 35 35  0  0  0  0  0  0  0  0999 V2000
   -2.1987    2.1435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3737    2.1435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6113    1.4289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1987    0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6113    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9612    2.8580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9612    1.4289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1362    1.4289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5783    1.8415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2927    1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5783    2.6665    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0072    1.8415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7218    1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4363    1.8415    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7218    0.6039    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6113    2.8580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4363    2.8580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3737    0.7145    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1987   -0.7145    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6113   -1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1987   -2.1435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3737   -2.1435    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9612   -2.8580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1362   -2.8580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2762   -2.1435    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1013   -2.1435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5138   -1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5138   -2.8580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1013   -0.7145    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3389   -1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7514   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7514   -2.1435    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5138    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3389    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0792    0.6320    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  3  4  1  0
  4  5  1  0
  2  6  2  0
  2  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 10 12  1  6
 12 13  1  0
 13 14  1  0
 13 15  2  0
  1 16  1  1
 16 17  1  0
  4 18  2  0
  5 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 27 29  1  1
 27 30  1  0
 30 31  1  0
 30 32  1  6
 29 33  1  0
 33 34  2  0
 10 35  1  0
 33 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5278932

    ---

Associated Targets(non-human)

Splenocyte (1641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 505.49Molecular Weight (Monoisotopic): 505.2132AlogP: -5.93#Rotatable Bonds: 4
Polar Surface Area: 259.54Molecular Species: NEUTRALHBA: 10HBD: 9
#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.92CX Basic pKa: CX LogP: -6.86CX LogD: -6.86
Aromatic Rings: Heavy Atoms: 35QED Weighted: 0.17Np Likeness Score: 0.69

References

1. Wu C, Cao X, Zhang X..  (2021)  VISTA inhibitors in cancer immunotherapy: a short perspective on recent progresses.,  12  (10.0): [PMID:34778768] [10.1039/D1MD00185J]

Source